查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球医疗互操作性解决方案市场按类型（软件,服务）,互操作性水平,最终用户和地区预测（至 2027 年）
市场调查报告书
商品编码
1253662

全球医疗互操作性解决方案市场按类型（软件,服务）,互操作性水平,最终用户和地区预测（至 2027 年）

Healthcare Interoperability Solutions Market by Type (Software, and Services), Interoperability Level, End User, and Region - Global Forecast to 2027
出版日期: | 出版商: MarketsandMarkets | 英文 217 Pages | 订单完成后即时交付

价格
简介目录

预计全球医疗互操作性解决方案市场规模将从 2022 年的 34 亿美元增至 2027 年的 62 亿美元，预测期内復合年增长率为 12.9%。

这个市场的增长是由对高效和具有成本效益的医疗保健服务的需求不断增长,政府为医疗保健互操作性提供资金以及电子健康记录 (EHR) 的快速采用所推动的。 然而，缺乏标准和使用老化的遗留系统将在预测期内在一定程度上抑制市场增长。

“按类型划分，健康信息交换 (HIE) 互操作性解决方案将在 2021 年增长最快”

按类型划分，HIE 互操作性解决方案将在 2021 年占据最大份额。 因素包括通过减少用药和医疗错误提高患者安全，通过消除不必要的文书工作和处理提高效率，以及提供给护理人员临床决策支持工具以提供更有效的护理和治疗等。

“从互操作级别来看，基础互操作将是2021年最大的部分”

从互操作性级别来看，基础互操作性部分在全球市场中占有最大份额。 其原因包括异构系统之间需要安全和准确的数据交换，以及对具有成本效益的基础级互操作性不断增长的需求。

“亚太地区在预测期内实现最高增长率”

亚太地区预计在预测期内以最高复合年增长率增长。 亚太地区的市场增长主要是由于政府加大了製定新的国家互操作性政策的力度，并与公共和私人医疗机构修改现有政策，医疗旅游的增加，以及对部署和整合医疗设备的需求不断增长等因素的推动和 HCIT 解决方案，以提供具有成本效益的高质量护理。

本报告按类型,互操作性水平和最终用户分析了全球医疗保健互操作性解决方案市场，包括市场基本面,当前发展,主要市场驱动因素和製约因素。□我们正在按地区调查市场趋势前景，市场竞争状况和主要公司概况。

内容

第一章介绍

第二章研究方法论

第 3 章执行摘要

第 4 章重要注意事项

第 5 章市场概述

  • 介绍
  • 市场动态
    • 司机
    • 约束因素
    • 机会
    • 任务
  • 价格分析
  • 价值链分析
  • 生态系统分析
  • 技术分析
  • 主要会议和活动（2023 年）
  • 监管分析
  • 波特的五力分析
  • 主要利益相关者和采购标准

第 6 章医疗保健互操作性解决方案市场：按类型

  • 介绍
  • 软件解决方案
    • 电子健康记录 (EHR) 互操作性解决方案
    • 实验室系统互操作性解决方案
    • 诊断成像系统的互操作性解决方案
    • 医疗保健信息交换 (HIE) 互操作性解决方案
    • 企业互操作性解决方案
    • 其他医疗互操作性解决方案
  • 服务

第 7 章医疗保健互操作性解决方案市场：按互操作性级别分类

  • 介绍
  • 基本互操作性
  • 结构互操作性
  • 语义互操作性

第 8 章医疗保健互操作性解决方案市场：最终用户

  • 介绍
  • 医疗保健提供者
    • 医院和诊所
    • 长期护理中心
    • 诊断和影像中心
    • 其他医疗保健提供者
  • 付款人
  • 药房

第 9 章按地区划分的医疗保健互操作性解决方案市场

  • 介绍
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 荷兰
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 澳大利亚
    • 其他亚太国家
  • 拉丁美洲
  • 中东和非洲

第10章竞争格局

  • 介绍
  • 医疗互操作性解决方案市场：公司采用的主要策略
  • 医疗互操作性解决方案市场：主要公司的市场排名
  • 市场份额分析
  • 主要公司的竞争评估象限
  • 初创企业/中小企业竞争评估象限
  • 竞争基准
    • 医疗互操作性解决方案市场：企业产品足迹
    • 医疗互操作性解决方案市场：企业区域足迹
    • 医疗互操作性解决方案市场：企业足迹
  • 竞争场景
    • 主要产品/服务的发布和批准
    • 主要交易

第11章公司简介

  • 主要公司
    • ORACLE HEALTH
    • EPIC SYSTEMS CORPORATION
    • INFOR, INC.
    • INTERSYSTEMS CORPORATION
    • KONINKLIJKE PHILIPS N.V.
    • VERADIGM LLC
    • COGNIZANT
    • CHANGE HEALTHCARE
    • NEXTGEN HEALTHCARE, INC.
    • MERATIVE
    • MEDICAL INFORMATION TECHNOLOGY, INC.
    • LYNIATE
    • OSP LABS
    • ORION HEALTH GROUP OF COMPANIES
    • ONYX TECHNOLOGY LLC
  • 其他企业
    • VISOLVE
    • JITTERBIT
    • INTERFACEWARE INC.
    • VIRTUSA CORP.
    • CONSENSUS CLOUD SOLUTIONS INC.
    • MPHRX
    • WIPRO
    • EMIDS
    • NALASHAA
    • DEEVITA LLC

第12章 附录

简介目录
Product Code: HIT 6989

The global healthcare interoperability solutions market is projected to reach USD 6.2 billion by 2027 from USD 3.4 billion in 2022, at a CAGR of 12.9% during the forecast period. Growth in this market is driven by the increased demand for efficient & cost-effective healthcare delivery, government funding for healthcare interoperability, and the rapid adoption of EHR. However, the lack of standards, and the use of outdated legacy systems are some factors restraining the growth of the healthcare interoperability solutions market to a certain extent during the forecast period.

"HIE Interoperability Solutions was the fastest-growing segment in the type of healthcare interoperability solutions market for software solutions in 2021"

HIE Interoperability Solutions accounted for the largest share of healthcare interoperability solutions market for software solutions in 2021. The large share of this segment can be attributed to the associated benefits such as improved patient safety by reducing medication and medical errors, increased efficiency by eliminating unnecessary paperwork and handling, as well as providing caregivers with clinical decision support tools for more effective care and treatment.

"Foundational Interoperability accounted for the largest segment by level of interoperaility in the healthcare interoperability solutions market in 2021"

Based on the level of interoperability, the foundational interoperability segment accounted for the largest share of the global healthcare interoperability solutions market. The large share of the foundational interoperability segment can be attributed to the need for safe and accurate data exchange across disparate systems as well as the growing demand for cost-effective basic-level interoperability.

"APAC to witness the highest growth rate during the forecast period."

The Asia Pacific market is projected to grow at the highest CAGR during the forecast period. Market growth in the APAC region is mainly driven by factors such as increasing government initiatives to unfold new national interoperability policies and rework existing policies with public and private healthcare organizations, growing medical tourism, and the growing need for the implementation and integration of medical devices and HCIT solutions to provide cost-effective and quality care to patients.

The break-down of primary participants is as mentioned below:

  • By Company Type - Tier 1: 55%, Tier 2: 30%, and Tier 3: 15%
  • By Designation - C-level: 50%, Director-level: 35%, and Others: 15%
  • By Region - North America: 48%, Europe: 32%, Asia Pacific: 15%, and Rest of the World: 5%.

Key players in the Healthcare interoperability solutions Market

The key players operating in the healthcare interoperability solutions market include Oracle Health (US), Epic Systems Corporation (US), Infor, Inc. (US), InterSystems Corporation (US), Koninklijke Philips N.V. (Netherlands), Veradigm LLC (US), Cognizant (US), Change Healthcare (US), NextGen Healthcare, Inc. (US), Merative (US), Medical Information Technology, Inc. (US), Lyniate (US), OSP Labs (US), Orion Health Group of Companies (New Zealand), Onyx Technology LLC (US). Some other players in the market include ViSolve (US), Jitterbit (US), iNTERFACEWARE Inc. (Canada), Virtusa Corp. (US), Consensus Cloud Solutions Inc. (US), MphRx (US), Wipro (India), eMids (US), Nalashaa (US), Deevita LLC (US).

Research Coverage:

The report analyzes the healthcare interoperability solutions market and aims at estimating the market size and future growth potential of various market segments, based on type, level of interoperability, end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.

This report provides insights on:

  • Analysis of key drivers (increasing demand for efficient and cost-effective healthcare delivery, government initiatives and regulations to enhance patient care and safety, emergence of new medical technologies, growing adoption of electronic health records), restraints (lack of accurate interoperability solutions across healthcare supply chain, lack of standards and protocols in IT businesses, use of outdated legacy systems in hospitals and clinic chains), opportunities (growing markets for healthcare interoperability solutions in developing countries, advancements in software technology for real-time data exchange),and challenges (increasing complexity due to lack of consistent data, shortage of skilled healthcare IT professionals, patient data security and privacy concerns in healthcare industry)influencing the growth of the healthcare interoperability solutions market.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the healthcare interoperability solutions market.
  • Market Development: Comprehensive information on the lucrative emerging markets, type, level of interoperability, end user, and region.
  • Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the healthcare interoperability solutions market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the healthcare interoperability solutions market like Oracle Health (US), Epic Systems Corporation (US), Infor, Inc. (US), InterSystems Corporation (US), Koninklijke Philips N.V. (Netherlands).

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
    • 1.2.2 MARKETS COVERED
    • FIGURE 1 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY REGION
    • 1.2.3 YEARS CONSIDERED
  • 1.3 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH APPROACH
    • FIGURE 2 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Primary sources
      • 2.1.2.2 Key data from primary sources
      • 2.1.2.3 Insights from primary experts
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 4 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
    • FIGURE 5 CAGR PROJECTIONS: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
    • 2.2.1 TOP-DOWN APPROACH
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 6 DATA TRIANGULATION METHODOLOGY
  • 2.4 MARKET RANKING ANALYSIS
  • 2.5 STUDY ASSUMPTIONS
  • 2.6 RESEARCH LIMITATIONS
    • 2.6.1 METHODOLOGY-RELATED LIMITATIONS
    • 2.6.2 SCOPE-RELATED LIMITATIONS
  • 2.7 RISK ASSESSMENT
    • TABLE 1 RISK ASSESSMENT: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
  • 2.8 IMPACT OF ECONOMIC RECESSION ON HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
    • 2.8.1 IMPACT OF RUSSIA-UKRAINE WAR
    • 2.8.2 IMPACT OF INFLATION

3 EXECUTIVE SUMMARY

    • FIGURE 7 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
    • FIGURE 8 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2022 VS. 2027 (USD MILLION)
    • FIGURE 9 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2022 VS. 2027 (USD MILLION)
    • FIGURE 10 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
    • FIGURE 11 GEOGRAPHICAL SNAPSHOT OF HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET

4 PREMIUM INSIGHTS

  • 4.1 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET OVERVIEW
    • FIGURE 12 GOVERNMENT INITIATIVES FOR ENHANCED PATIENT CARE AND SAFETY TO DRIVE MARKET
  • 4.2 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE AND COUNTRY (2021)
    • FIGURE 13 SERVICES SEGMENT ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET IN 2021
  • 4.3 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES
    • FIGURE 14 ASIA PACIFIC TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
  • 4.4 REGIONAL MIX: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET (2022-2027)
    • FIGURE 15 NORTH AMERICA TO DOMINATE HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET DURING FORECAST PERIOD
  • 4.5 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: DEVELOPED VS. DEVELOPING MARKETS, 2022 VS. 2027
    • FIGURE 16 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 17 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing demand for efficient and cost-effective healthcare delivery
      • 5.2.1.2 Government initiatives and regulations to enhance patient care and safety
      • 5.2.1.3 Emergence of new medical technologies
      • 5.2.1.4 Growing adoption of electronic health records
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Lack of accurate interoperability solutions across healthcare supply chain
      • 5.2.2.2 Lack of standards and protocols in IT businesses
      • 5.2.2.3 Use of outdated legacy systems in hospitals and clinic chains
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growing markets for healthcare interoperability solutions in developing countries
      • 5.2.3.2 Advancements in software technology for real-time data exchange
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Increasing complexity due to lack of consistent data
      • 5.2.4.2 Shortage of skilled healthcare IT professionals
      • 5.2.4.3 Patient data security and privacy concerns in healthcare industry
  • 5.3 PRICING ANALYSIS
  • 5.4 VALUE CHAIN ANALYSIS
    • FIGURE 18 VALUE CHAIN ANALYSIS OF HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
  • 5.5 ECOSYSTEM ANALYSIS
    • FIGURE 19 ECOSYSTEM ANALYSIS OF HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
  • 5.6 TECHNOLOGY ANALYSIS
    • 5.6.1 APPLICATION PROGRAMMING INTERFACES
    • 5.6.2 CLOUD-BASED SOLUTIONS
    • 5.6.3 BLOCKCHAIN TECHNOLOGY
    • 5.6.4 FAST HEALTHCARE INTEROPERABILITY RESOURCES
    • 5.6.5 ARTIFICIAL INTELLIGENCE
    • 5.6.6 MACHINE LEARNING
  • 5.7 KEY CONFERENCES AND EVENTS IN 2023
    • TABLE 2 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS IN 2023
  • 5.8 REGULATORY ANALYSIS
    • 5.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 3 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 4 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 5 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 6 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.8.2 LAWS, REGULATIONS, AND STANDARDS
    • TABLE 7 KEY REGULATIONS AND STANDARDS GOVERNING HEALTHCARE INTEROPERABILITY TECHNOLOGIES GLOBALLY
  • 5.9 PORTER'S FIVE FORCES ANALYSIS
    • FIGURE 20 PORTER'S FIVE FORCES ANALYSIS IN HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
    • TABLE 8 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • 5.10 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 APPLICATIONS
    • TABLE 9 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 APPLICATIONS (%)
    • 5.10.2 BUYING CRITERIA
    • FIGURE 22 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS
    • TABLE 10 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS

6 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE

  • 6.1 INTRODUCTION
    • TABLE 11 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020-2027 (USD MILLION)
  • 6.2 SOFTWARE SOLUTIONS
    • TABLE 12 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 13 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.2.1 EHR INTEROPERABILITY SOLUTIONS
      • 6.2.1.1 Large installation base of EHR systems to ensure single and continuous readable documents for physicians
    • TABLE 14 EHR INTEROPERABILITY SOLUTIONS OFFERED BY KEY PLAYERS
    • TABLE 15 EHR INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.2.2 LAB SYSTEM INTEROPERABILITY SOLUTIONS
      • 6.2.2.1 Increasing cost of operations and decreasing reimbursements for laboratory services to boost market
    • TABLE 16 LAB SYSTEM INTEROPERABILITY SOLUTIONS OFFERED BY KEY PLAYERS
    • TABLE 17 LAB SYSTEM INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.2.3 IMAGING SYSTEM INTEROPERABILITY SOLUTIONS
      • 6.2.3.1 Rising need for data interoperability and increasing usage of smart devices to drive market
    • TABLE 18 IMAGING SYSTEM INTEROPERABILITY SOLUTIONS OFFERED BY KEY PLAYERS
    • TABLE 19 IMAGING SYSTEM INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.2.4 HIE INTEROPERABILITY SOLUTIONS
      • 6.2.4.1 Large investments by federal governments to propel market
    • TABLE 20 HIE INTEROPERABILITY SOLUTIONS OFFERED BY KEY PLAYERS
    • TABLE 21 HIE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.2.5 ENTERPRISE INTEROPERABILITY SOLUTIONS
      • 6.2.5.1 Advancing software technology and rising demand for expanded care delivery to augment market
    • TABLE 22 ENTERPRISE INTEROPERABILITY SOLUTIONS OFFERED BY KEY PLAYERS
    • TABLE 23 ENTERPRISE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.2.6 OTHER HEALTHCARE INTEROPERABILITY SOLUTIONS
    • TABLE 24 OTHER HEALTHCARE INTEROPERABILITY SOLUTIONS OFFERED BY KEY PLAYERS
    • TABLE 25 OTHER HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
  • 6.3 SERVICES
    • 6.3.1 INCREASING ADOPTION OF HEALTHCARE IT INTEGRATION SERVICES BY PROVIDERS TO AUGMENT MARKET
    • TABLE 26 SERVICES OFFERED BY KEY PLAYERS
    • TABLE 27 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SERVICES, BY COUNTRY, 2020-2027 (USD MILLION)

7 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL

  • 7.1 INTRODUCTION
    • TABLE 28 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020-2027 (USD MILLION)
  • 7.2 FOUNDATIONAL INTEROPERABILITY
    • 7.2.1 NEED FOR SAFE AND ACCURATE DATA EXCHANGE ACROSS DISPARATE SYSTEMS TO FUEL MARKET
    • TABLE 29 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR FOUNDATIONAL INTEROPERABILITY, BY COUNTRY, 2020-2027 (USD MILLION)
  • 7.3 STRUCTURAL INTEROPERABILITY
    • 7.3.1 STRUCTURAL INTEROPERABILITY TO ENSURE INTERPRETATION OF DATA EXCHANGE BETWEEN SYSTEMS AT DATA FIELD LEVEL
    • TABLE 30 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR STRUCTURAL INTEROPERABILITY, BY COUNTRY, 2020-2027 (USD MILLION)
  • 7.4 SEMANTIC INTEROPERABILITY
    • 7.4.1 SEMANTIC INTEROPERABILITY TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
    • TABLE 31 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SEMANTIC INTEROPERABILITY, BY COUNTRY, 2020-2027 (USD MILLION)

8 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER

  • 8.1 INTRODUCTION
    • TABLE 32 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 8.2 HEALTHCARE PROVIDERS
    • TABLE 33 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 34 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2020-2027 (USD MILLION)
    • 8.2.1 HOSPITALS & CLINICS
      • 8.2.1.1 Increasing patient volume and rising need to reduce errors in data management to augment market
    • TABLE 35 HOSPITALS & CLINICS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 8.2.2 LONG-TERM CARE CENTERS
      • 8.2.2.1 Increasing number of care centers and need to maintain compliance with medical reforms to propel market
    • TABLE 36 LONG-TERM CARE CENTERS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 8.2.3 DIAGNOSTIC & IMAGING CENTERS
      • 8.2.3.1 Increasing volume of clinical data and need to streamline imaging workflows to drive market
    • TABLE 37 DIAGNOSTIC & IMAGING CENTERS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 8.2.4 OTHER HEALTHCARE PROVIDERS
    • TABLE 38 OTHER HEALTHCARE PROVIDERS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
  • 8.3 HEALTHCARE PAYERS
    • 8.3.1 ADOPTION OF HEALTHCARE INTEROPERABILITY BY PAYERS TO DECREASE HOSPITAL STAYS AND REPEAT TESTS
    • TABLE 39 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PAYERS, BY COUNTRY, 2020-2027 (USD MILLION)
  • 8.4 PHARMACIES
    • 8.4.1 PHARMACIES TO USE HEALTHCARE INFORMATION EXCHANGE SOLUTIONS FOR INDIVIDUALIZED PATIENT CARE AND SUPPORT
    • TABLE 40 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR PHARMACIES, BY COUNTRY, 2020-2027 (USD MILLION)

9 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY REGION

  • 9.1 INTRODUCTION
    • TABLE 41 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 9.2 NORTH AMERICA
    • FIGURE 23 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET SNAPSHOT
    • TABLE 42 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 43 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 44 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 45 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020-2027 (USD MILLION)
    • TABLE 46 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 47 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020-2027 (USD MILLION)
    • 9.2.1 US
      • 9.2.1.1 Growing need to curtail healthcare costs to drive market
    • TABLE 48 US: KEY MACROINDICATORS
    • TABLE 49 US: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 50 US: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 51 US: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020-2027 (USD MILLION)
    • TABLE 52 US: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 53 US: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020-2027 (USD MILLION)
    • 9.2.2 CANADA
      • 9.2.2.1 Increasing healthcare digitization to support market
    • TABLE 54 CANADA: KEY MACROINDICATORS
    • TABLE 55 CANADA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 56 CANADA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 57 CANADA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020-2027 (USD MILLION)
    • TABLE 58 CANADA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 59 CANADA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020-2027 (USD MILLION)
  • 9.3 EUROPE
    • TABLE 60 EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 61 EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 62 EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 63 EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020-2027 (USD MILLION)
    • TABLE 64 EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 65 EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020-2027 (USD MILLION)
    • 9.3.1 GERMANY
      • 9.3.1.1 Modernized healthcare system and increased healthcare expenditure to augment market
    • TABLE 66 GERMANY: KEY MACROINDICATORS
    • TABLE 67 GERMANY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 68 GERMANY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 69 GERMANY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020-2027 (USD MILLION)
    • TABLE 70 GERMANY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 71 GERMANY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020-2027 (USD MILLION)
    • 9.3.2 UK
      • 9.3.2.1 Government initiatives and NHS programs to drive demand
    • TABLE 72 UK: KEY MACROINDICATORS
    • TABLE 73 UK: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 74 UK: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 75 UK: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020-2027 (USD MILLION)
    • TABLE 76 UK: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 77 UK: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020-2027 (USD MILLION)
    • 9.3.3 FRANCE
      • 9.3.3.1 Government measures to curtail healthcare expenditures to fuel market
    • TABLE 78 FRANCE: KEY MACROINDICATORS
    • TABLE 79 FRANCE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 80 FRANCE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 81 FRANCE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020-2027 (USD MILLION)
    • TABLE 82 FRANCE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 83 FRANCE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020-2027 (USD MILLION)
    • 9.3.4 ITALY
      • 9.3.4.1 Increasing government initiatives in HCIT technology implementation to aid market
    • TABLE 84 ITALY: KEY MACROINDICATORS
    • TABLE 85 ITALY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 86 ITALY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 87 ITALY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020-2027 (USD MILLION)
    • TABLE 88 ITALY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 89 ITALY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020-2027 (USD MILLION)
    • 9.3.5 NETHERLANDS
      • 9.3.5.1 Robust healthcare infrastructure and eHealth initiatives to propel market
    • TABLE 90 NETHERLANDS: KEY MACROINDICATORS
    • TABLE 91 NETHERLANDS: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 92 NETHERLANDS: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 93 NETHERLANDS: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020-2027 (USD MILLION)
    • TABLE 94 NETHERLANDS: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 95 NETHERLANDS: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020-2027 (USD MILLION)
    • 9.3.6 REST OF EUROPE
    • TABLE 96 REST OF EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 97 REST OF EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 98 REST OF EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020-2027 (USD MILLION)
    • TABLE 99 REST OF EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 100 REST OF EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020-2027 (USD MILLION)
  • 9.4 ASIA PACIFIC
    • FIGURE 24 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET SNAPSHOT
    • TABLE 101 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 102 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 103 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 104 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020-2027 (USD MILLION)
    • TABLE 105 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 106 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020-2027 (USD MILLION)
    • 9.4.1 JAPAN
      • 9.4.1.1 Japan to be largest healthcare interoperability market in Asia Pacific during forecast period
    • TABLE 107 JAPAN: KEY MACROINDICATORS
    • TABLE 108 JAPAN: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 109 JAPAN: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 110 JAPAN: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020-2027 (USD MILLION)
    • TABLE 111 JAPAN: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 112 JAPAN: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020-2027 (USD MILLION)
    • 9.4.2 AUSTRALIA
      • 9.4.2.1 Increasing government initiatives for better clinical communication to drive market
    • TABLE 113 AUSTRALIA: KEY MACROINDICATORS
    • TABLE 114 AUSTRALIA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 115 AUSTRALIA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 116 AUSTRALIA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020-2027 (USD MILLION)
    • TABLE 117 AUSTRALIA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 118 AUSTRALIA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020-2027 (USD MILLION)
    • 9.4.3 REST OF ASIA PACIFIC
    • TABLE 119 REST OF ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 120 REST OF ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 121 REST OF ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020-2027 (USD MILLION)
    • TABLE 122 REST OF ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 123 REST OF ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020-2027 (USD MILLION)
  • 9.5 LATIN AMERICA
    • 9.5.1 IMPLEMENTATION OF FAVORABLE GOVERNMENT INITIATIVES TO DRIVE MARKET
    • TABLE 124 LATIN AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 125 LATIN AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 126 LATIN AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020-2027 (USD MILLION)
    • TABLE 127 LATIN AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 128 LATIN AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020-2027 (USD MILLION)
  • 9.6 MIDDLE EAST & AFRICA
    • 9.6.1 INCREASED ESTABLISHMENT OF NEW HOSPITALS TO DRIVE MARKET
    • TABLE 129 MIDDLE EAST & AFRICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 130 MIDDLE EAST & AFRICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 131 MIDDLE EAST & AFRICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020-2027 (USD MILLION)
    • TABLE 132 MIDDLE EAST & AFRICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 133 MIDDLE EAST & AFRICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020-2027 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 INTRODUCTION
  • 10.2 KEY STRATEGIES ADOPTED BY PLAYERS IN HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
    • TABLE 134 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: KEY DEVELOPMENTS (JANUARY 2019-MARCH 2023)
  • 10.3 MARKET RANKING OF KEY PLAYERS IN HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
    • FIGURE 25 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: MARKET RANKING OF KEY PLAYERS (2022)
  • 10.4 MARKET SHARE ANALYSIS
    • 10.4.1 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
    • TABLE 135 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2021
  • 10.5 COMPETITIVE EVALUATION QUADRANT FOR KEY PLAYERS
    • 10.5.1 STARS
    • 10.5.2 EMERGING LEADERS
    • 10.5.3 PERVASIVE PLAYERS
    • 10.5.4 PARTICIPANTS
    • FIGURE 26 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: COMPETITIVE LEADERSHIP MAPPING (2022)
  • 10.6 COMPETITIVE EVALUATION QUADRANT FOR START-UPS/SMES
    • 10.6.1 PROGRESSIVE COMPANIES
    • 10.6.2 DYNAMIC COMPANIES
    • 10.6.3 STARTING BLOCKS
    • 10.6.4 RESPONSIVE COMPANIES
    • FIGURE 27 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES (2022)
  • 10.7 COMPETITIVE BENCHMARKING
    • 10.7.1 PRODUCT FOOTPRINT OF PLAYERS IN HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
    • TABLE 136 COMPANY PRODUCT FOOTPRINT
    • 10.7.2 REGIONAL FOOTPRINT OF PLAYERS IN HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
    • TABLE 137 COMPANY REGION FOOTPRINT
    • 10.7.3 FOOTPRINT OF PLAYERS IN HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
    • TABLE 138 COMPANY FOOTPRINT
  • 10.8 COMPETITIVE SCENARIO
    • 10.8.1 KEY PRODUCT/SERVICE LAUNCHES AND APPROVALS
    • TABLE 139 KEY PRODUCT/SERVICE LAUNCHES AND APPROVALS, 2019-2022
    • 10.8.2 KEY DEALS
    • TABLE 140 KEY DEALS, 2019-2022

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS

(Business Overview, Products/Services/Solutions offered, Recent Developments, and MnM View)*

    • 11.1.1 ORACLE HEALTH
    • TABLE 141 ORACLE HEALTH: COMPANY OVERVIEW
    • FIGURE 28 ORACLE HEALTH: COMPANY SNAPSHOT (2021)
    • 11.1.2 EPIC SYSTEMS CORPORATION
    • TABLE 142 EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW
    • 11.1.3 INFOR, INC.
    • TABLE 143 INFOR, INC.: COMPANY OVERVIEW
    • FIGURE 29 INFOR, INC.: COMPANY SNAPSHOT (2019)
    • 11.1.4 INTERSYSTEMS CORPORATION
    • TABLE 144 INTERSYSTEMS CORPORATION: COMPANY OVERVIEW
    • 11.1.5 KONINKLIJKE PHILIPS N.V.
    • TABLE 145 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
    • FIGURE 30 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2021)
    • 11.1.6 VERADIGM LLC
    • TABLE 146 VERADIGM LLC: COMPANY OVERVIEW
    • FIGURE 31 VERADIGM LLC: COMPANY SNAPSHOT (2021)
    • 11.1.7 COGNIZANT
    • TABLE 147 COGNIZANT: COMPANY OVERVIEW
    • FIGURE 32 COGNIZANT: COMPANY SNAPSHOT (2021)
    • 11.1.8 CHANGE HEALTHCARE
    • TABLE 148 CHANGE HEALTHCARE: COMPANY OVERVIEW
    • FIGURE 33 CHANGE HEALTHCARE: COMPANY SNAPSHOT (2021)
    • 11.1.9 NEXTGEN HEALTHCARE, INC.
    • TABLE 149 NEXTGEN HEALTHCARE, INC.: COMPANY OVERVIEW
    • FIGURE 34 NEXTGEN HEALTHCARE, INC.: COMPANY SNAPSHOT (2020)
    • 11.1.10 MERATIVE
    • TABLE 150 MERATIVE: COMPANY OVERVIEW
    • 11.1.11 MEDICAL INFORMATION TECHNOLOGY, INC.
    • TABLE 151 MEDICAL INFORMATION TECHNOLOGY, INC.: COMPANY OVERVIEW
    • FIGURE 35 MEDICAL INFORMATION TECHNOLOGY, INC.: COMPANY SNAPSHOT (2019)
    • 11.1.12 LYNIATE
    • TABLE 152 LYNIATE: COMPANY OVERVIEW
    • 11.1.13 OSP LABS
    • TABLE 153 OSP LABS: COMPANY OVERVIEW
    • 11.1.14 ORION HEALTH GROUP OF COMPANIES
    • TABLE 154 ORION HEALTH GROUP OF COMPANIES: COMPANY OVERVIEW
    • FIGURE 36 ORION HEALTH GROUP OF COMPANIES: COMPANY SNAPSHOT (2021)
    • 11.1.15 ONYX TECHNOLOGY LLC
    • TABLE 155 ONYX TECHNOLOGY LLC: COMPANY OVERVIEW
  • 11.2 OTHER PLAYERS
    • 11.2.1 VISOLVE
    • TABLE 156 VISOLVE: COMPANY OVERVIEW
    • 11.2.2 JITTERBIT
    • TABLE 157 JITTERBIT: COMPANY OVERVIEW
    • 11.2.3 INTERFACEWARE INC.
    • TABLE 158 INTERFACEWARE INC.: COMPANY OVERVIEW
    • 11.2.4 VIRTUSA CORP.
    • TABLE 159 VIRTUSA CORP.: COMPANY OVERVIEW
    • FIGURE 37 VIRTUSA CORP.: COMPANY SNAPSHOT (2020)
    • 11.2.5 CONSENSUS CLOUD SOLUTIONS INC.
    • TABLE 160 CONSENSUS CLOUD SOLUTIONS INC.: COMPANY OVERVIEW
    • 11.2.6 MPHRX
    • 11.2.7 WIPRO
    • 11.2.8 EMIDS
    • 11.2.9 NALASHAA
    • 11.2.10 DEEVITA LLC
  • Business Overview, Products/Services/Solutions offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS